tiprankstipranks
Heron Therapeutics narrows 2024 revenue view to $140M-$146M from $138M-$158M
The Fly

Heron Therapeutics narrows 2024 revenue view to $140M-$146M from $138M-$158M

Consensus for 2024 revenue is $148.4M. Raises 2024 adjusted EBITDA view to $2M-$5M from (22M)-$3M.

Pick the best stocks and maximize your portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App